Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/133596
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism |
Author: | Klebe, S. Golmard, J.-L. Nalls, M.A. Saad, M. Singleton, A.B. Bras, J.M. Hardy, J. Simon-Sanchez, J. Heutink, P. Kuhlenbaeumer, G. Charfi, R. Klein, C. Hagenah, J. Gasser, T. Wurster, I. Lesage, S. Lorenz, D. Deuschl, G. Durif, F. Pollak, P. et al. |
Citation: | Journal of Neurology, Neurosurgery and Psychiatry, 2013; 84(6):666-673 |
Publisher: | BMJ Publishing Group |
Issue Date: | 2013 |
ISSN: | 0022-3050 1468-330X |
Statement of Responsibility: | Stephan Klebe ... Tamas Revesz ... et al. |
Abstract: | The catechol-O-methyltranferase (COMT) is one of the main enzymes that metabolise dopamine in the brain. The Val158Met polymorphism in the COMT gene (rs4680) causes a trimodal distribution of high (Val/Val), intermediate (Val/Met) and low (Met/Met) enzyme activity. We tested whether the Val158Met polymorphism is a modifier of the age at onset (AAO) in Parkinson's disease (PD). The rs4680 was genotyped in a total of 16 609 subjects from five independent cohorts of European and North American origin (5886 patients with PD and 10 723 healthy controls). The multivariate analysis for comparing PD and control groups was based on a stepwise logistic regression, with gender, age and cohort origin included in the initial model. The multivariate analysis of the AAO was a mixed linear model, with COMT genotype and gender considered as fixed effects and cohort and cohort-gender interaction as random effects. COMT genotype was coded as a quantitative variable, assuming a codominant genetic effect. The distribution of the COMT polymorphism was not significantly different in patients and controls (p=0.22). The Val allele had a significant effect on the AAO with a younger AAO in patients with the Val/Val (57.1±13.9, p=0.03) than the Val/Met (57.4±13.9) and the Met/Met genotypes (58.3±13.5). The difference was greater in men (1.9 years between Val/Val and Met/Met, p=0.007) than in women (0.2 years, p=0.81). Thus, the Val158Met COMT polymorphism is not associated with PD in the Caucasian population but acts as a modifier of the AAO in PD with a sexual dimorphism: the Val allele is associated with a younger AAO in men with idiopathic PD. |
Keywords: | French Parkinson's Disease Genetics Study Group International Parkinson's Disease Genomics Consortium (IPDGC) Humans Parkinson Disease Catechol O-Methyltransferase Age of Onset Sex Factors Genotype Polymorphism, Single Nucleotide Aged Middle Aged Male |
Rights: | © 2013, BMJ Publishing Group Ltd. All rights reserved. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode |
DOI: | 10.1136/jnnp-2012-304475 |
Published version: | http://dx.doi.org/10.1136/jnnp-2012-304475 |
Appears in Collections: | Medicine publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_133596.pdf | Published version | 191.13 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.